Another study demonstrated that the expression of immune checkpoint inhibitor, programmed death-1 ligand 1 (PD-L1), can be suppressed by EZH2 in HCC through methylation of its encoding gene and IRF1 which is an essential transcription factor for the expression of PD-L1 (45). This evidence concerns the gene EZH2 and hepatocellular carcinoma.